well $1 is realistic based on: low float of about 30mil, promising biotech already in here pretty much whose product has multiple cancer indications and orphan drug desig., the two (count em) very capable and well experienced and connected, down ass directors just added today to the company profile over at OTCMarkets, and the already fully reporting and current squeaky clean shell they just took control of on behalf of $$$ ONCOLIX $$$
Phase I trials already in progress, if not completed. IMO YOU BETTER GET TICKETS!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.